Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
- Author
- BANTSCHEFF, Marcus1 ; EBERHARD, Dirk1 ; READER, Valérie2 ; SWEETMAN, Gavain1 ; BAUER, Andreas1 ; BOUWMEESTER, Tewis1 ; HOPF, Carsten1 ; KRUSE, Ulrich1 ; NEUBAUER, Gitte1 ; RAMSDEN, Nigel2 ; RICK, Jens1 ; KUSTER, Bernhard1 ; ABRAHAM, Yann1 ; DREWES, Gerard1 ; BASTUCK, Sonja1 ; BOESCHE, Markus1 ; HOBSON, Scott1 ; MATHIESON, Toby1 ; PERRIN, Jessica1 ; RAIDA, Manfred1 ; RAU, Christina1
[1] Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg, Germany
[2] Cellzome UK Ltd., Chesterford Research Park, Cambridge CB10 1XL, United Kingdom - Source
Nature biotechnology (Print). 2007, Vol 25, Num 9, pp 1035-1044, 10 p ; ref : 50 ref
- CODEN
- NABIF9
- ISSN
- 1087-0156
- Scientific domain
- Biotechnology
- Publisher
- Nature Publishing Group, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Analyse quantitative Cible Inhibiteur de la tyrosine kinase Interaction moléculaire Mécanisme action Médicament Protéomique ABL kinase
- Keyword (en)
- Quantitative analysis Target Tyrosine kinase inhibitor Molecular interaction Mechanism of action Drug Proteomics
- Keyword (es)
- Análisis cuantitativo Blanco Inhibidor tyrosine kinase Interacción molecular Mecanismo acción Medicamento Proteómica
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A31 Biotechnology / 002A31D Industrial applications and implications. Economical aspects / 002A31D01 Health. Pharmaceutical industry / 002A31D01G Miscellaneous
- Discipline
- Biotechnology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20635395
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1038/nbt1328 
https://dx.doi.org/10.1038/nbt1328
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:15:\"10.1038\/nbt1328\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:95:\"Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Nature biotechnology (Print)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Nat. biotechnol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1035\";s:8:\"\u0000*\u0000epage\";s:4:\"1044\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1087-0156\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"BANTSCHEFF\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Marcus\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:20:{i:0;s:14:\"EBERHARD, Dirk\";i:1;s:16:\"READER, Val\u00e9rie\";i:2;s:16:\"SWEETMAN, Gavain\";i:3;s:14:\"BAUER, Andreas\";i:4;s:18:\"BOUWMEESTER, Tewis\";i:5;s:13:\"HOPF, Carsten\";i:6;s:13:\"KRUSE, Ulrich\";i:7;s:15:\"NEUBAUER, Gitte\";i:8;s:14:\"RAMSDEN, Nigel\";i:9;s:10:\"RICK, Jens\";i:10;s:16:\"KUSTER, Bernhard\";i:11;s:13:\"ABRAHAM, Yann\";i:12;s:14:\"DREWES, Gerard\";i:13;s:14:\"BASTUCK, Sonja\";i:14;s:15:\"BOESCHE, Markus\";i:15;s:13:\"HOBSON, Scott\";i:16;s:15:\"MATHIESON, Toby\";i:17;s:15:\"PERRIN, Jessica\";i:18;s:14:\"RAIDA, Manfred\";i:19;s:14:\"RAU, Christina\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NABIF9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:95:\"Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:15:\"10.1038\/nbt1328\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:95:\"Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Nature biotechnology (Print)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Nat. biotechnol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1035\";s:8:\"\u0000*\u0000epage\";s:4:\"1044\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1087-0156\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"BANTSCHEFF\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Marcus\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:20:{i:0;s:14:\"EBERHARD, Dirk\";i:1;s:16:\"READER, Val\u00e9rie\";i:2;s:16:\"SWEETMAN, Gavain\";i:3;s:14:\"BAUER, Andreas\";i:4;s:18:\"BOUWMEESTER, Tewis\";i:5;s:13:\"HOPF, Carsten\";i:6;s:13:\"KRUSE, Ulrich\";i:7;s:15:\"NEUBAUER, Gitte\";i:8;s:14:\"RAMSDEN, Nigel\";i:9;s:10:\"RICK, Jens\";i:10;s:16:\"KUSTER, Bernhard\";i:11;s:13:\"ABRAHAM, Yann\";i:12;s:14:\"DREWES, Gerard\";i:13;s:14:\"BASTUCK, Sonja\";i:14;s:15:\"BOESCHE, Markus\";i:15;s:13:\"HOBSON, Scott\";i:16;s:15:\"MATHIESON, Toby\";i:17;s:15:\"PERRIN, Jessica\";i:18;s:14:\"RAIDA, Manfred\";i:19;s:14:\"RAU, Christina\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NABIF9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:95:\"Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:15:\"10.1038\/nbt1328\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:15:\"10.1038\/nbt1328\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:95:\"Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Nature biotechnology (Print)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Nat. biotechnol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1035\";s:8:\"\u0000*\u0000epage\";s:4:\"1044\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1087-0156\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"BANTSCHEFF\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Marcus\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:20:{i:0;s:14:\"EBERHARD, Dirk\";i:1;s:16:\"READER, Val\u00e9rie\";i:2;s:16:\"SWEETMAN, Gavain\";i:3;s:14:\"BAUER, Andreas\";i:4;s:18:\"BOUWMEESTER, Tewis\";i:5;s:13:\"HOPF, Carsten\";i:6;s:13:\"KRUSE, Ulrich\";i:7;s:15:\"NEUBAUER, Gitte\";i:8;s:14:\"RAMSDEN, Nigel\";i:9;s:10:\"RICK, Jens\";i:10;s:16:\"KUSTER, Bernhard\";i:11;s:13:\"ABRAHAM, Yann\";i:12;s:14:\"DREWES, Gerard\";i:13;s:14:\"BASTUCK, Sonja\";i:14;s:15:\"BOESCHE, Markus\";i:15;s:13:\"HOBSON, Scott\";i:16;s:15:\"MATHIESON, Toby\";i:17;s:15:\"PERRIN, Jessica\";i:18;s:14:\"RAIDA, Manfred\";i:19;s:14:\"RAU, Christina\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NABIF9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:95:\"Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:15:\"10.1038\/nbt1328\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:95:\"Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Nature biotechnology (Print)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Nat. biotechnol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1035\";s:8:\"\u0000*\u0000epage\";s:4:\"1044\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1087-0156\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"BANTSCHEFF\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Marcus\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:20:{i:0;s:14:\"EBERHARD, Dirk\";i:1;s:16:\"READER, Val\u00e9rie\";i:2;s:16:\"SWEETMAN, Gavain\";i:3;s:14:\"BAUER, Andreas\";i:4;s:18:\"BOUWMEESTER, Tewis\";i:5;s:13:\"HOPF, Carsten\";i:6;s:13:\"KRUSE, Ulrich\";i:7;s:15:\"NEUBAUER, Gitte\";i:8;s:14:\"RAMSDEN, Nigel\";i:9;s:10:\"RICK, Jens\";i:10;s:16:\"KUSTER, Bernhard\";i:11;s:13:\"ABRAHAM, Yann\";i:12;s:14:\"DREWES, Gerard\";i:13;s:14:\"BASTUCK, Sonja\";i:14;s:15:\"BOESCHE, Markus\";i:15;s:13:\"HOBSON, Scott\";i:16;s:15:\"MATHIESON, Toby\";i:17;s:15:\"PERRIN, Jessica\";i:18;s:14:\"RAIDA, Manfred\";i:19;s:14:\"RAU, Christina\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NABIF9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:95:\"Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:15:\"10.1038\/nbt1328\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:95:\"Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Nature biotechnology (Print)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Nat. biotechnol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1035\";s:8:\"\u0000*\u0000epage\";s:4:\"1044\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1087-0156\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"BANTSCHEFF\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Marcus\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:20:{i:0;s:14:\"EBERHARD, Dirk\";i:1;s:16:\"READER, Val\u00e9rie\";i:2;s:16:\"SWEETMAN, Gavain\";i:3;s:14:\"BAUER, Andreas\";i:4;s:18:\"BOUWMEESTER, Tewis\";i:5;s:13:\"HOPF, Carsten\";i:6;s:13:\"KRUSE, Ulrich\";i:7;s:15:\"NEUBAUER, Gitte\";i:8;s:14:\"RAMSDEN, Nigel\";i:9;s:10:\"RICK, Jens\";i:10;s:16:\"KUSTER, Bernhard\";i:11;s:13:\"ABRAHAM, Yann\";i:12;s:14:\"DREWES, Gerard\";i:13;s:14:\"BASTUCK, Sonja\";i:14;s:15:\"BOESCHE, Markus\";i:15;s:13:\"HOBSON, Scott\";i:16;s:15:\"MATHIESON, Toby\";i:17;s:15:\"PERRIN, Jessica\";i:18;s:14:\"RAIDA, Manfred\";i:19;s:14:\"RAU, Christina\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NABIF9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:95:\"Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
